HCA Healthcare (NYSE:HCA – Get Free Report)‘s stock had its “outperform” rating restated by equities researchers at Leerink Partners in a research report issued on Friday, Benzinga reports. They presently have a $492.00 price objective on the stock. Leerink Partners’ price objective indicates a potential upside of 14.12% from the company’s previous close.
HCA has been the topic of several other research reports. Truist Financial dropped their price target on shares of HCA Healthcare from $535.00 to $495.00 and set a “buy” rating on the stock in a research report on Monday, July 27th. Wells Fargo & Company upped their price target on HCA Healthcare from $369.00 to $381.00 and gave the stock an “equal weight” rating in a report on Monday, August 3rd. Raymond James Financial set a $528.00 price objective on HCA Healthcare in a research note on Tuesday, July 7th. Barclays cut their target price on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating on the stock in a research note on Monday, July 27th. Finally, Royal Bank Of Canada reiterated an “outperform” rating and set a $435.00 price target on shares of HCA Healthcare in a report on Tuesday, September 8th. Fourteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $462.27.
Get Our Latest Stock Report on HCA
HCA Healthcare Stock Up 0.5%
HCA Healthcare (NYSE:HCA – Get Free Report) last issued its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. During the same period in the prior year, the firm earned $6.84 earnings per share. HCA Healthcare’s revenue for the quarter was up 8.7% on a year-over-year basis. Equities analysts predict that HCA Healthcare will post 29.42 earnings per share for the current fiscal year.
Hedge Funds Weigh In On HCA Healthcare
Large investors have recently made changes to their positions in the stock. MidFirst Bank bought a new stake in shares of HCA Healthcare during the 2nd quarter valued at $28,000. Clearstead Trust LLC purchased a new stake in HCA Healthcare in the second quarter worth about $29,000. Cedar Mountain Advisors LLC bought a new position in shares of HCA Healthcare during the 1st quarter valued at approximately $33,000. MCF Advisors LLC raised its stake in HCA Healthcare by 213.0% during the 4th quarter. MCF Advisors LLC now owns 72 shares of the company’s stock worth $34,000 after acquiring an additional 49 shares during the period. Finally, Basepoint Wealth LLC bought a new position in shares of HCA Healthcare in the fourth quarter worth approximately $35,000. 62.73% of the stock is owned by institutional investors.
About HCA Healthcare
HCA Healthcare, Inc (NYSE:HCA) is a healthcare services company that operates hospitals and other healthcare facilities. Its network provides a broad range of medical services, including emergency care, inpatient and outpatient treatment, surgery, diagnostic services, and maternity care.
The company also operates ambulatory surgery centers, urgent care facilities, physician practices, and other outpatient locations. HCA Healthcare serves patients through facilities located across the United States, as well as through HCA Healthcare UK, its healthcare operations in the United Kingdom.
HCA Healthcare was founded in 1968 by Dr.
Read More
- Five stocks we like better than HCA Healthcare
- 3 Zero-Fee ETFs Worth More Than Their Cost
- 3 Nimble Free Cash Flow Names With Light Assets
- Intel’s Ohio Lifeline? Why the SK Hynix Talks Matter
- Generac Plugs into Amazon for an $8B AI-Powered Deal
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
